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CORONARY ARTERY DISEASE 
IN TYPE-2 DIABETIC WOMEN
INTRODUCTION
Diabetes is expanding in pandemic proportions worldwide. 
According to the recent statistical reports from the World Health 
Organization, India leads the world with the largest number of 
diabetic subjects1   
Classification
DM is classified on the basis of the pathogenic process that leads to 
hyperglycemia.
The two broad categories of DM are designated type 1 and type 2. Type 1 
diabetes is the result of complete or near-total insulin deficiency. Type 2 
DM is a heterogeneous group of disorders characterized by variable 
degrees of insulin resistance, impaired insulin secretion, and increased 
glucose production.
Type 2 DM is preceded by a period of abnormal glucose homeostasis 
classified as impaired fasting glucose (IFG) or impaired glucose tolerance 
(IGT).
The pathophysiological process of atherosclerosis in diabetic subjects is 
accelerated by several factors such as hyperglycemia, insulin resistance, 
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abnormal lipid profile, oxidative modification of lipoproteins, increased 
blood pressure, altered rate of fibrinolysis etc. 
Diabetes and coronary artery disease  
Diabetes mellitus is a disorder characterized by hyperglycemia and 
occurs due to impaired insulin secretion and/or impaired insulin 
sensitivity. Though diabetes mellitus is a metabolic disease, it is also 
considered as a vascular disease. Affection of the medium sized blood 
vessels leads to coronary artery disease (CAD), peripheral vascular 
disease (PVD) and cerebrovascular disease (CVD). Indeed, CAD 
accounts for more than 50% of the mortality among type 2 diabetic 
subjects. All the manifestations of CAD are at least two fold more 
common in patients with diabetes than in non diabetic individuals 2 
    
Cardiovascular risk factors in diabetic subjects  
Diabetes mellitus and CAD share many common risk factors. According 
to Reaven3 diabetes and CAD are constituents of the metabolic syndrome 
in which insulin resistance plays a contributory role. The term 
metabolic syndrome describe the clustering of risk factors 
including hypertension, dyslipidemia, hyperglycemia, insulin 
resistance 4and abdominal obesity 5.This cluster has been shown to 
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predict death in type 2 diabetic subjects 6 .  In addition a number of other 
factors for CAD such as atherothrombotic factors, fibrinolytic factors, 
coagulation factors and inflammatory markers have also been described 
in diabetic patients.
Hyperglycemia and CAD  
Increase in plasma glucose levels have long been recognized as a risk 
factor for CAD. 
Hypertension and CAD  
Studies have shown that an increase by 5 mm of Hg is associated with 
34% increase in risk for cardiovascular disease  7. 
Dyslipidemia and CAD
 
The term diabetic dyslipidemia refers to a constellation of abnormalities 
including high triglycerides, low HDL cholesterol and changes in LDL 
cholesterol qualitatively with an excess of small dense LDL. The excess 
risk for CAD seen among diabetes is attributed to diabetic dyslipidemia, 
particularly increase in small dense LDL
Hypercoagulation and Hypofibrinolysis and CAD  
Diabetes is associated with various abnormalities of the haemostatic and 
fibrinolytic system. Indeed diabetes is considered to be a hypercoagulable 
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and hypofibrinolytic state. An increased level of fibrinogen and PAI-1 has 
been indicated by both clinical and epidemiological studies among 
diabetic subjects 8.Reduced fibrinolysis may predispose diabetic patients 
to deposit fibrin and this may exacerbate accumulation of LDL, as 
dyslipidemia is a common phenomenon among these subjects..
Lipoprotein(a) and CAD  
Lipoprotein(a) is a complex of apolipoprotein (a) and LDL. Lp(a) has a 
striking homology and common genetic determinants with plasminogen 
and can competitively inhibit plasminogen activity leading to impaired 
fibrinolysis.Lipoprotein (a) has also been implicated in enhanced 
oxidation and foam cell formation. Lp(a) has an independent association 
with CAD in Type 2 diabetic patients 9. An increase in lipoprotein (a) was 
associated with increase in carotid intimal medial thickening, a preclinical 
atherosclerotic marker10. This suggest that Lp(a) is associated with CAD 
even at an early stage of atherosclerosis and thus could play a major role 
in the development of CAD.
Homocysteine and CAD  
Homocysteine, a sulphur containing amino acid is an atherothrombogenic 
moiety, which triggers platelet adhesion in cell culture and has been 
shown to be strongly associated with CAD in several studies11. 
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 Inflammatory markers and CAD  
There is emerging evidences that inflammatory processes and 
specific immune mechanisms are involved in atherogenesis12. 
Atherosclerotic lesions are heavily infiltrated by cellular 
components associated with inflammation like macrophages and T 
lymphocytes13. It has been shown that inflammatory markers 
predict future cardiovascular events. C-reactive protein (CRP) has 
recently gained lot of interest,14 and studies have shown CRP to be 
associated with both diabetes and CAD 15 16.
Ischemic Heart Disease
Ischemic heart disease (IHD) is a condition in which there is an 
inadequate supply of blood and oxygen to a portion of the 
myocardium; it typically occurs when there is an imbalance 
between myocardial oxygen supply and demand. The most 
common cause of myocardial ischemia is atherosclerotic disease 
of an epicardial coronary artery (or arteries) sufficient to cause a 
regional reduction in myocardial blood flow and inadequate 
perfusion of the myocardium supplied by the involved coronary 
artery.
Unstable Angina, ST and  Non-ST-Elevation Myocardial Infarction: 
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Patients with ischemic heart disease fall into two large groups: patients 
with chronic coronary artery disease (CAD) who most commonly present 
with stable angina and patients with acute coronary syndromes (ACSs). 
The latter group, in turn, is composed of patients with acute myocardial 
infarction (MI) with ST-segment elevation on their presenting 
electrocardiogram (STEMI)and those with unstable angina and non-ST-
segment elevation MI (UA/NSTEMI) .The relative incidence of 
UA/NSTEMI compared to STEMI appears to be increasing.
Almost one-half of patients with UA/NSTEMI are women, while more 
than three-fourths of patients with STEMI are men.
Cardiac biomarkers
Cardiac troponins are currently the preferred biomarkers for myocardial 
damage because of their high sensitivity and specificity. CK-MB is the 
best alternative, if cardiac troponin assays are not available. 
Determinations of total CK, aspartate aminotransferase, and lactate 
dehydrogenase are no longer recommended. 
Risk of CAD in women
The relative risk for fatal coronary heart disease associated with 
diabetes is 50% higher in women than it is in men. This greater 
excess coronary risk may be explained by more adverse 
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cardiovascular risk profiles among women with diabetes, combined 
with possible disparities in treatment that favour men.17
Various risk factors like diabetes, dyslipidemia, hypertension, 
hypercoagulation, hypofibrinolysis and inflammation are associated with 
CAD. Some of these factors are modifiable by therapeutic interventions. 
Most of these factors can be modified by life style modifications like 
dietary modification, regular physical activity, weight reduction and 
cessation of smoking. Control of CAD in diabetic patients would 
however require a multi-pronged approach to reduce the risk of CAD, 
which includes in addition to life style modifications, tight control of 
hyperglycemia, blood pressure and hyperlipidemia as shown in the recent 
Steno - 2 study  18.
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AIMS AND OBJECTIVES
1.To study the incidence of coronary artery disease in women 
with type-2 diabetes mellitus.
2.To assess the association between glycemic control and the 
risk of coronary artery disease in type 2 diabetic women.
3.To evaluate the role of risk factors in the development of 
coronary artery disease in type 2 diabetic women.
14
REVIEW OF LITERATURE
Diabetes mellitus and CAD
Although diabetes may be a problem of glucose metabolism, 
the American Heart Association (AHA) has recently stated that 
“diabetes is a cardiovascular disease” 19 .
The Framingham Heart Study revealed one to five fold increase in PAD, 
CHF, CAD, MI, and sudden death in patients with diabetes mellitus.
Both type 1 and type 2 diabetes are powerful and independent 
risk factors for CAD, stroke, and peripheral arterial 
disease 20,21,22. 
Type 2 diabetes patients without a prior MI have a similar risk for 
coronary artery–related events as nondiabetic individuals who have had a 
prior MI.
When patients with diabetes develop clinical events, they 
sustain a worse prognosis than patients without diabetes 23. 
The absence of chest pain ("silent ischemia") is common in individuals 
with diabetes, and a thorough cardiac evaluation is indicated in 
individuals undergoing major surgical procedures.
CAD is more likely to involve multiple vessels in individuals with DM.
15
RISK FACTORS
Risk factors for macrovascular disease in diabetic individuals include 
dyslipidemia, hypertension, obesity, reduced physical activity, and 
cigarette smoking. 
Additional risk factors more prevalent in the diabetic population include 
microalbuminuria, an elevation of serum creatinine, and abnormal platelet 
function.
Insulin resistance, as reflected by elevated serum insulin levels, is 
associated with an increased risk of cardiovascular complications in 
individuals with and without DM.
Individuals with insulin resistance and type 2 DM have elevated levels of 
plasminogen activator inhibitors (especially PAI-1) and fibrinogen, which 
enhances the coagulation process and impairs fibrinolysis, thus favoring 
the development of thrombosis. 
Diabetes is also associated with endothelial, vascular smooth-muscle, and 
platelet dysfunction
16
 Role of Inflammatory Markers
Increased serum levels of glycated albumin, hsCRP and TNF-alpha are 
associated with the presence and severity of CAD and renal impairment 
in patients with T2DM.24
A  prospective  study showed  the relationship between 
cardiovascular risk factors, selected biomarkers (high-sensitivity C-
reactive protein [hs-CRP], interleukin [IL]-6, and osteoprotegerin 
[OPG]), and the progression of coronary artery calcification (CAC) 
in type 2 diabetic subjects. 
Coronary artery calcification is pathognomonic of coronary 
atherosclerosis. Osteoprotegerin is a signaling molecule involved 
in bone remodeling that has been implicated in the regulation of 
vascular calcification and atherogenesis.
In a study on Inflammatory markers, insulin resistance and carotid 
intima-media thickness in North-Indian type 2 diabetic subjects,
Plasma glucose and insulin (fasting and after 2 hours of 75 gm of oral 
glucose), lipids and serum levels of C-reactive protein (CRP), fibrinogen 
and Tumour Necrosis Factor (TNF)-alpha were measured. Carotid 
(Intima-Medial Thickness) IMT was measured using high "resolution B-
Mode ultrasonography. Insulin resistance was calculated using HOMA-IR 
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model. Electrocardiogram (ECG) and exercise ECG were recorded for the 
evidence of coronary heart disease (CHD).HOMA-IR, waist hip ratio, 
serum triglycerides, serum cholesterol, fasting serum insulin and CRP 
were significant predictor of IMT. Concentrations of inflammatory 
markers were significantly higher in diabetic patients than in control 
group. Inflammatory markers are associated with type 2 diabetes but only 
CRP is associated with development of accelerated atherosclerosis  and 
subsequent  development of CHD. 25
• Levels of fasting plasma glucose, body mass index, serum total 
lipids, serum total cholesterol, serum triglycerides and blood pressure of 
177 Libyan diabetic patients were determined. The mean levels of all 
variables except plasma glucose were significantly higher in the female 
patients than their male counterparts. Correlations were present between 
blood pressure levels and age/body mass index/serum total lipids. There 
was a significant correlation between systolic pressure levels and the 
duration of diabetes. Serum cholesterol and serum triglyceride levels 
correlated with diastolic blood pressure levels only.26
Sub-clinical vascular disease in type 2 diabetic subjects: 
A low ABI is highly prevalent in subjects with diabetes and is 
related to age, duration of diabetes, smoking habit, and 
hypertriglyceridemia. Although chronic complications are frequently 
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associated with a low ABI, only renal damage is independently 
associated with peripheral artery disease.27
A study of Prevalence of subclinical atherosclerosis in asymptomatic 
diabetic patients by 64-slice computed tomography showed that the 
prevalence of coronary plaques detectable by 64-slice CT in 
asymptomatic diabetic patients is very high.28
The study concluded that baseline CAC severity and suboptimal 
glycemic control are strong risk factors for CAC progression in type 
2 diabetic subjects.29
The Diabetes Heart Study concluded that QT duration correlates 
with the amount of coronary artery calcium score( CAC) in a 
predominantly diabetic population. The association between QT 
duration and CAC is driven by QRS and not JT interval duration.30
DM and Peripheral Vascular Disease
•   Diabetic patients with diabetic foot were more likely to have a 
higher prevalence of cardiovascular risk factors such as 
hypercholesterolemia, hypertriglyceridemia, hyperuricemia, and 
microalbuminuria or proteinuria, a higher prevalence of a previous 
cardiovascular morbidity (coronary artery disease, transient ischemic 
attack/ischemic stroke, diabetic retinopathy), and a higher prevalence of 
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subclinical cardiovascular disease. Furthermore, diabetic patients with 
foot ulceration showed, on a 5-year follow-up, a higher incidence of new-
onset vascular events (coronary artery disease, transient ischemic 
attack/ischemic stroke, diabetic retinopathy). At multivariate analysis, 
duration of diabetes, age, hemoglobin A1c, and DFS maintained a 
significant association with cardiovascular morbidity; but DFS presence 
showed the highest hazard ratio.31
Carotid ultrasound, blood lipids and waist determination can 
predict a future coronary  revascularisation  in the type 2 diabetic 
cohort.32
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The presence of arterial hypertension, hyperlipidemia, physical 
inactivity, intermittent claudication, the value of systolic pressure, 
BMI, waist and hip measurement, glycemia and blood lipid fraction 
(total cholesterol, HDL, LDL, non-HDL, triglycerides) were entered 
in a model. Ultrasound measurements: carotid IMT, presence of 
carotid plaques and stenosis, and ABI were also included in the 
analysis. Based on the univariate and multivariate findings, the 
presence of internal carotid artery (ICA) stenosis (OR 4,562, 95% CI 
1,327-15,687), carotid plaque (OR 1,465, 95% CI 0,829-2,591), and 
increased waist measurement (OR 1,371, 95% CI 0,757-2,483) were 
found as significant independent predictors of future PCI. LDL and 
non HDL cholesterol were found to be factors independently 
associated with the need for future CABG by univariate analysis, 
which was not confirmed by multivariate analysis. 
Metabolic syndrome and CAD
The most prevalent metabolic syndrome component was arterial 
hypertension (78.3%). Low HDL was detected in 67.9%, 
hypertriglicerydaemia in 62.7%, and an increased waist in 49.8% 
of the study population.33
In Type 2 DM and HTN without epicardial coronary stenosis, an 
impairment of coronary flow reserve is demonstrable. This is partly 
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explained by an increased left-ventricular mass, able to condition 
the hyperemic stimulation of myocardial blood flow.34
BP Control
All people with diabetes-regardless of age, gender, and race and 
ethnicity-may benefit from efforts to prevent hypertension. The control of 
elevated blood pressure is inadequate and broad-based efforts are needed 
to improve blood pressure control.35
Stress and risk of CAD
A significant proportion of patients report 'high' levels of subjective stress 
in the 2-4 week period preceding acute coronary events. This study 
confirms the association of subjective stress and acute coronary events36,37
Role of genetics  
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in 
subclinical cardiovascular disease in the Diabetes Heart Study:
Epoxide hydrolase is involved in metabolism of vasoactive and 
anti-inflammatory epoxyeicosatrienoic acids to their corresponding 
diols. Consequently, epoxide hydrolase 2 (EPHX2) is a candidate 
cardiovascular disease (CVD) gene. The R287Q polymorphism 
was associated with carotid artery calcified plaque (CarCP) in 
EAs. Other EPHX2 polymorphisms were associated with coronary 
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artery calcified plaque (CorCP), CarCP or carotid artery intima-
media thickness (IMT).The results provide additional evidence that 
EPHX2 contributes to the risk of subclinical CVD, although the true 
trait defining polymorphisms may not be identified and the effect 
size could be small.38
Presence of T2DM significantly modulates the vascular risk 
conferred by the PAI-1 -675 4G/5G polymorphism in 
angiographied coronary patients.39
CAD in women
Type 2 diabetes increases relative risk of cardiovascular 
disease two- to fourfold compared with the risk in the general 
population 40414243.The increase in cardiovascular risk is 
particularly high in women. 
The protection against atherosclerosis in premenopausal 
women is almost completely lost in women with diabetes 44.
Diabetic postmenopausal women develop more severe CAD 
compared to non-diabetic women. This association is independent 
of other predisposing factors and suggests an independent effect 
of T2DM on the atherosclerotic process, at least in women after 
menopause.45
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Excess risk of fatal coronary heart disease associated with diabetes in 
men and women  was studied in a meta-analysis of 37 
prospective cohort studies.
The  study concluded that the relative risk for fatal coronary heart disease 
associated with diabetes is 50% higher in women than it is in men. This 
greater excess coronary risk may be explained by more adverse 
cardiovascular risk profiles among women with diabetes, combined with 
possible disparities in treatment that favour men.46
Screening in Asymptomatic women
The results obtained from a study of CAD in asymptomatic women 
suggested a high prevalence of CAD in diabetic women. Thus, this 
population should be investigated from the cardiovascular point of view 
even without cardiac symptom. Of the noninvasive diagnostic methods 
used, dipyridamole MPS was the one that showed the highest 
discrimination power in relation to diabetic women with CAD.47
Gestational diabetes, pregnancy hypertension, and late vascular 
disease:
As a forme fruste of later type 2 diabetes, GDM-affected gravidas 
are identified as at risk of diabetes-related atherosclerosis, 
glomerular disruption, and pathogenic retinal angio-genesis. Late 
pregnancy preeclampsia is associated with elevated mid-
24
pregnancy BMI, blood pressure, fasting glucose and insulin, urate, 
and C-reactive protein, suggestive of metabolic and immune 
dysregulation..48 
Hyperleptinemia
Hyperleptinemia as a Robust Risk Factor of Coronary Artery Disease 
and Metabolic Syndrome in Type 2 Diabetic Patients:
Leptin has been linked to adiposity, insulin resistance, and 
coronary artery disease (CAD). Other variables  associated with 
CAD were age, sex, hypertension, low-HDL cholesterolemia, and 
hsCRP. Hyperleptinemia might be an independent risk factor for 
CAD and MS in diabetic subjects. And the simultaneous 
measurement of insulin resistance and leptin concentration might 
be helpful for screening subjects with a high-risk of CAD.49 
Cardiac parasympathetic dysfunction in type 2 diabetes 
mellitusA study on Independent predictors of cardiac 
parasympathetic dysfunction in type 2 diabetes mellitus concluded 
that parasympathetic dysfunction mainly coexists with somatic 
neuropathy. It may be isolated, or precede detection of other 
complications. Age and female gender are the other predictors of 
reduced heart rate response to deep breathing in type 2 diabetes 
mellitus.50
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In a study of Insulin resistance as predictor of the angiographic severity 
and extent of coronary artery disease Patients with more severe degree of 
IR had a more severe, extensive, and distal type of CAD than patients 
with lower degree of IR51
 Albuminuria
In diabetic patients with albuminuria, Doppler strain and SR imaging 
detected subclinical LV systolic and diastolic dysfunction; and 
albuminuria was associated with myocardial dysfunction in diabetic 
patients without overt heart disease.52
OX-LDL
Elevated levels of ox-LDL, can serve as an independent and significant 
predictor for future cardiac events in type 2 diabetic patients with CAD.53
Uncomplicated diabetes mellitus is equivalent for coronary artery 
disease- New support from novel angiographic myocardial 
perfusion-myocardial blush:
Diabetes mellitus (DM) is accepted as coronary heart disease 
equivalent even in the presence of normal coronary artery on 
coronary angiography. Evaluation of microvascular circulation with 
novel angiographic perfusion indexes "myocardial blush grade" 
(MBG) and "myocardial filling time" (MFT) in patients with 
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uncomplicated DM showed that microvascular function is worse in 
subjects with both diabetes and coronary artery disease than in 
non-diabetic subjects with coronary artery disease. The most 
impressive result of the study was diabetic patients with normal 
coronary angiography had similar MBG and MFT results with non-
diabetic coronary artery disease patients. DM causes 
microvascular dysfunction even when one has normal coronary 
angiography and this put them in the same risk group with non-
diabetic coronary artery patients.54
Waist-to-height Ratio and Coronary Artery Disease :
Waist circumference (WC), waist-to-hip ratio (WHR), waist-to-
height ratio (WHeiR), and BMI are indicators for obesity. A study 
examined the usefulness of these indicators for coronary artery 
disease (CAD) in Taiwanese type 2 diabetic patients. Only WHeiR 
was significant for both sexes and it also showed the greatest 
decrease in -2 log likelihood, the largest magnitude of odds ratio, 
and the smallest AIC while compared with the other indices in 
either sex. It  concluded that WHeiR has the superiority of 
independent association with CAD and the highest magnitude of 
association than WC, WHR, and BMI in both sexes. The 
usefulness of WHeiR should not be neglected in clinical practice.55
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In addition to CAD, cerebrovascular disease is increased in individuals 
with DM (threefold increase in stroke).
 Individuals with DM have an increased incidence of CHF. The etiology 
of this abnormality is probably multifactorial and includes factors such as 
myocardial ischemia from atherosclerosis, hypertension, and myocardial 
cell dysfunction secondary to chronic hyperglycemia.
Endothelial dysfunction in diabetes mellitus
The vascular endothelium has been shown to be important in 
modulating blood cell-vessel wall interaction, regulating blood 
flow, angiogenesis, lipoprotein metabolism, and vasomotion.
The mechanism of this increased vascular resistance is 
probably partly due to the increase in the intercellular signal 
transduction kinase, protein kinase C (PKC) 56575859 which result 
in an increase in endothelin-1.
An important mediator in maintaining vascular homeostasis is 
endothelium-derived relaxing factor (EDRF) 60 which has been 
found to be nitric oxide. 61which results in relaxation of 
vascular smooth muscle 62636465
Type 2 diabetes have an impairment of both endothelial-
dependent and endothelial-independent (smooth muscle) 
vasodilator function in contrast to type 1 DM patients 66,67.
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Acute hyperglycemia impairs endothelial-dependent 
vasodilation in both macro- and microvessels 68 .
Insulin also may play a role. Insulin results in vasodilation due 
in part to nitric oxide production.
Several studies have shown that high doses of vitamin C can 
improve endothelial-dependent vasodilation in patients with 
both type 1 and type 2 diabetes 6970.
Intensive lipid lowering by statin therapy does not improve 
vasoreactivity in patients with type 2 diabetes, suggesting that 
mechanisms other than dyslipidemia are responsible for 
endothelial dysfunction 71.
Endogenous competitive inhibitor of nitric oxide synthase, 
asymmetric dimethylarginine (ADMA) 72 ADMA has been found 
to be elevated in subjects with diabetes 7374.
The detection of impaired fasting glucose is a strong risk 
factor for type 2 diabetes. 
Recent evidence suggests that either lifestyle intervention or 
treatment with metformin also can reduce the development of 
diabetes in persons at high risk 75 .
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MATERIALS AND METHODS
Design and data collection:
A descriptive study design was adopted and samples were 
collected by systematic random sampling method.
Ethics commitee  approval was obtained and informed consent 
was taken from participants.
Inclusion critera:
All type 2 diabetic women attending diabetology clinic,medical 
wards and ICCU are included & 170 patients selected by 
systematic random sampling method.
Exclusion criteria:
Type 1 diabetic women,children,men& pregnant diabetic 
patients. 
Measures:
 Each patient was interviewed to obtain detailed history and 
examined thoroughly.
Height ,weight  and waist circumferences were examined with 
standardized techniques and equipments.
BMI  and Waist height ratios were computed. 
BMI calculated by dividing weight in Kg by height in M 2 
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Blood pressure was examined in supine position in the right 
upper limb. 
Serum total cholesterol and triglycerides measurement were 
done after 12hours of fasting.
ECG and Echocardiographic evaluation were done for coronary 
artery disease patients.
Statistical analysis:
Statistical analysis  was done using SPSS software for windows.
Means compared by applying student’s t-test,proportions compared by z 
test. 
31
DIAGNOSTIC CRITERIA
FOR DIBETES MELLITUS: 
The National Diabetes Data Group and World Health Organization 
diagnostic criteria was used
       Criteria for the Diagnosis of Diabetes Mellitus
1.Symptoms of diabetes plus random blood glucose concentration 11.1 
mmol/L (200 mg/dL)or 
2.Fasting plasma glucose 7.0 mmol/L (126 mg/dL)or 
3.Two-hour plasma glucose 11.1 mmol/L (200 mg/dL) during an oral 
glucose tolerance test
In our study 1,2 criteria  were used. 
FOR HYPERTENSION:
Joint National Conference –VII criteria followed
Category Systolic(mm Hg) Diastolic(mm Hg)
Optimal <120 <80
Prehypertenson 120-139 80-89
Stage-1 140-159 90-99
Stage-2 >/=160 >/=100
 
FOR CORONARY ARTERY DISEASE:
History, ECG changes and echocardiographic criteria were used.
32
HISTORY
chest discomfort, usually described as heaviness, pressure, squeezing, 
smothering, or choking, and only rarely as frank pain. Angina is usually 
crescendo-decrescendo in nature, typically lasts 2–5 min, and can radiate 
to either shoulder and to both arms, especially the ulnar surfaces of the 
forearm and hand. It can also arise in or radiate to the back, interscapular 
region, root of the neck, jaw, teeth, and epigastrium. 
Stable angina pectoris is characterized by chest or arm discomfort that 
may not be described as pain but is reproducibly associated with physical 
exertion or stress and is relieved within 5–10 min by rest and/or 
sublingual nitroglycerin. 
UA is defined as angina pectoris or equivalent ischemic discomfort with 
at least one of three features: (1) it occurs at rest (or with minimal 
exertion), usually lasting >10 min; (2) it is severe and of new onset (i.e., 
within the prior 4–6 weeks); and/or (3) it occurs with a crescendo pattern 
(i.e., distinctly more severe, prolonged, or frequent than previously). 
Symptoms of AMI
The classic symptom of AMI is precordial or retrosternal discomfort that 
is commonly described as a pressure, crushing, aching, or burning 
sensation. Radiation of the discomfort to the neck, back, or arms 
frequently occurs, and the pain is usually persistent. The discomfort 
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typically achieves maximum intensity over several minutes and can be 
associated with nausea, diaphoresis, generalized weakness, and a fear of 
impending death. Some patients, particular the elderly, may also present 
with syncope, unexplained nausea and vomiting, acute confusion, 
agitation, or palpitations.
ELECTROCARDIOGRAM76,77
ISCHEMIA
a)Sub endocardial ischemia:
A combination of  two diagnostic criteria is required in at least one ECG 
lead for the diagnosis.
1)At least1.0 mm( 0.10mv )depression at the J point.
2)Either  a horizontal or downward slope towards the end of the ST 
segment at its junction with the T wave.
b)Transmural ischemia
presence of one of the following criteria is required for the diagnosis.
1)elevation of the origin of the ST segment  at its junction( Jpoint)with 
the QRS of (a)>=1.0 mm( 0.10mv )in two or more limb 
leads(b)>=2.0mm(0.2mv)in two or more precordial leads,OR
2)Depression of the origin of the ST segment at the J point of >=2.0 
mm(0.20mv)in at least two of the three leads V1-V3.
MYOCARDIAL INFARCTION
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a)convex ST segment elevation in corresponding leads(early).
b)QS complexes or abnormal Q waves ie. Q waves of  0.04 seconds or 
more in width or
25% or more of the voltage  of  the R wave in the same lead or 
Both in the corresponding leads(late)
c)T wave inversion (typically deep,symmetric) in the corresponding 
leads(late)
ANATOMICALZONE ECG ZONE
INFERIOR WALL LII,III,Avf
ANTERO SEPTALWALL V1-V4
EXTENSIVE ANTERIOR WALL LI,AVL,V1-V6
ANTERO LATERAL WALL LI,AVL,V5-V6
INFERO LATERAL WALL LII,LIII,AVF,AVL,V5-V6
ECHOCARDIOGRAPHY
Abnormalities of wall motion on two-dimensional echocardiography 
,estimation of left ventricular (LV) function,presence of right ventricular 
(RV) infarction, ventricular aneurysm, pericardial effusion, and LV 
thrombus.
Doppler echocardiography for the detection and quantitation of a 
ventricular septal defect and mitral regurgitation, two serious 
complications of STEMI. 
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        ECG showing acute inferior wall myocardial infarction            
                      Chest x-ray showing cardiomegaly
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ANALYSIS OF RESULTS
 ANALYSIS OF VARIOUS SYMPTOMS OF DIABETES
In our study of the 170 diabetic women the following symptom 
frequencies were observed in relation with the level of post prandial 
blood sugar(PPBS).
SYMPTOMS OF DIABETES PPBS<14
0
140-200 PPBS>200
POLYDIPSIA 1 21 21
POLYPHAGIA 0 18 7
POLYURIA 2 33 35
WEIGHTLOSS 0 2 0
FATIGUE 1 36 22
PRURITUS 0 3 4
INFECTIONS 0 0 2
ANGINAL PAIN 0 24 24
NONANGINAL PAIN 1 10 5
DIMVISION 0 5 3
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ANALYSIS OF VARIOUS SYMPTOMS OF CORONARY ARTERY 
DISEASE
 Out of the 170 patients analysed 64 patients developed various forms of 
coronary artery disease( CAD).The symptom frequencies observed in 
those patients are given below.
SYMPTOMS CAD IN 
ECG
ECG 
NORMAL
P value
CHESTPAIN 47 1 <0.05
16 0 NS
DYSPNOEA 5 5
DIAPHORESIS 2 0
PALPITATION 12 6 <0.05
EDEMA 6 5
GIDDINESS 20 11 <0.05
DYSPEPSIA 21 20 <0.05
VOMITING 2 0
AGE DISTRIBUTION
Among the 64 patients who developed coronary artery disease 26 patients 
belonged to the 50-60 years age group(40.6%),19 patients in the 40-50 
years age group(29.7%),13 patients in the 60-70 years age 
group(20.3%),4.7% both in 30-40 and 70-80 years age groups.
AGE GROUP  NO:OF CAD 
PATIENTS
PERCENTAGE OF 
CAD PATIENTS
30-40 3 4.7%
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40-50 19 29.7%
50-60 26 40.6%
60-70 13 20.3%
70-80 3 4.7%
>80 0 .0%
OCCUPATION AND CAD
In our study the following results were obtained  regarding the correlation 
of occupation and CAD.Among the 64  CAD patients 26 had sedentary 
jobs(40.6%),14 were manual labourers(21.9%).
OCCUPATION NO: OF CAD 
PATIENTS
PERCENTAG
E
Manual labourer 14 21.9%
Moderate exertion 24 37.5%
Sedentary Job 26 40.6%
INCIDENCE IN PREMENOPAUSAL V/S POSTMENOPAUSAL 
WOMEN
Among the 170 patients studied 34(20%)were premenopausal 
and136(80%) were postmenopausal. Out of the 64 CAD patents 51 
(79.7%)were postmenopausal women and 13(20.3%) were 
premenopausal.
MENSTRUAL H/O COUNT PERCENTAGE
Premenopausal 34 20.0%
Postmenopausal 136 80.0%
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MENSTRUAL H/O CAD IN ECG PERCENTAGE
PREMENOPAUSAL 13 20.3%
POSTMENOPAUSAL 51 79.7%
STRESS AND CAD
 In the study a significant proportion (28 out of the 64 patients) reported 
'high' levels of subjective stress in the 2-4 week period preceding acute 
coronary events. 
STRESS CAD IN ECG NORMAL ECG P VALUE
ABSENT 36 104 <0.05
PRESENT 28 2 <0.05
BODY MASS INDEX AND CAD
BMI of 18-25 is considerd to be normal,25.1-29.9 as overweight,>30 as 
obese,<18 as underweight.In the study  out of 64 CAD patients 38 
(59.4%)were overweight,16(25%) had normal weight,10(15.6%) were 
obese and none of them were underweight. 
BMI CAD CAD% TOTAL TOTAL%
BMI<18 0 .0% 0 .0%
BMI 18.10-
25
16 25.0% 41 24.1%
25-29.99 38 59.4% 106 62.4%
BMI>30 10 15.6% 23 13.5%
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ANALYSIS OF WAIST CIRCUMFERENCE
 In our study, 43 out of the 64 CAD patients (67.2%)  had waist 
circumference >88 cm,21(32.8%) had waist circumference <88 cm. 
WAIST 
CIRCUMFERENCE
NO: OF CAD 
PATIENTS
PERCENTAGE
>88CM 43 67.2%
<88CM 21 32.8%
ANALYSIS OF WAIST- HEIGHT RATIO
This study examined the, usefulness of waist-to-height ratio (WHeiR)as 
an indicator for coronary artery disease (CAD).36(56.3%) CAD patients 
had WHeiR<0.56 and 28(43.8%) had WHeiR>0.56.
WAIST- HEIGHT 
RATIO
NO:OF CAD 
PATIENTS
PERCENTAGE
<0.56 36 56.3%
>0.56 28 43.8%
ANALYSIS OF HYPERTENSION
Among the 170 patients studied 36( 21.1% )had hypertension
SBP WITHOUT 
CAD
COUNT PERCENTAGE
140-160 23 13.5%
>160 13 7.6%
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Age group of the hypertensive patients were as shown below. Largest 
number of hypertensives (39.3%)  were in the 50-60 years age group.
AGE SBP PERCENTAGE
30-40 1 2.13
40-50 11 30.60
50-60 15 39.30
60-70 6 19.75
70-80 2 6.00
>80 1 2.13
A significant percentage of CAD 23.4% with p value <0.05 were 
observed among patients with systolic BP in the range of 140-160 mm of 
Hg.
SBP CAD PERCENTAGE P VALUE
<120 12 18.8% NS
120-140 24 37.5% NS
140-160 15 23.4% <0.05
>160 13 20.3% NS
DBP COUNT PERCENTAGE
90-100 10 5.9%
>100 1 .6%
GLYCEMIC CONTROL
 In the study of PPBS and the incidence of CAD,maximum incidence is 
found in 200-250 mg% range(34.4%);26% in 140-200mg% range,20.3% 
in 250-300mg% range and 0 % in<140 mg % range.
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PPBS&GLYCEMIC 
CONTROL
NO:OF CAD 
PATIENTS
PERCENTAGE
<140 0 0%
140-200 17 26.6%
200-250 22 34.4%
250-300 13 20.3%
300-350 9 14.1%
>350 3 4.7%
In study of FBS and incidence of coronary artery disease significant 
number of patients had FBS >125 mg%.
FBS CAD PERCENTAGE
<110 8 12.5%
110-125 6 9.4%
>125 50 78.1%
SERUM CHOLESTEROL
In the study significant correlation was found between 
hypercholesterolemia and the incidence of coronary artery disease.67.2% 
of coronary artery disease patients had moderate hypercholesterolemia.
TOTAL 
CHOLESTEROL
 NO: OF CAD 
PATIENTS
PERCENTAGE P VALUE
DESIRABLE 15 23.4% NS
MODERATE 
HYPERCHOL
43 67.2% NS
HYPERCHOL 6 9.4% <0.05
43
 SERUM TRIGLYCERIDES
In the study of correlation between serum triglycerides and the incidence 
of coronary artery disease,60.9% of the CAD patients had triglycerides 
>150mg%.
TRIGLYCERIDES NO: OF CAD
 PATIENTS
PERCENTAGE
<150 25 39.1%
>150 39 60.9%
ECG  ANALYSIS 
Among the 170 type 2 diabetic women studied,64(37.6%)had evidence of 
coronary artery disease.
No of patients with ischaemic heart disease excluding myocardial 
infarction = 48
No of patients with myocardial infarction=16
NSTEMI=10
STEMI=6
Various conduction defects in CAD patients=7
Various arrhythmias in CAD patients=3
ECG COUNT PERCENTAGE
CAHD 64 37.6%
NORMAL 106 62.4%
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ECG COUNT PERCENTAGE
ARRHYTHMIAS 0 .0%
CONDUCTION DEFECTS 0 .0%
IHD 42 24.7%
IHD&ARRHYTHMIAS 1 .6%
IHD&CD 5 2.9%
NORMAL 106 62.4%
NSTEMI&ARRHYTHMIAS 1 .6%
NSTEMI&CD 1 .6%
NSTEMI 8 4.7%
STEMI 3 1.8%
STEMI&ARRHYTHMIAS 2 1.2%
STEMI&CD 1 .6%
ECHOCARDIOGRAPHY
 In the echocardiographic evaluation of CAD patients,all patients with 
myocardial infarction had regional wall motion abnormalities,one patient 
had papillary muscle dysfunction and four had left ventricular 
dysfuncyion. 
ECHO COUNT PERCENTAGE
CHAMBER 
ENLARGEMENT
0 0%
PMD 0 0%
RWMA 14 8.2%
RWMA&LVD 4 2.4%
R,P 1 0.6%
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DISCUSSION
ANALYSIS OF CORONARY ARTERY DISEASE
Incidence of coronary artey disease in diabetes mellitus varies from 11% 
to 77% as reported by various authors.
The present study showed an incidence of 37.6%. The study conducted 
by Banerjee j.c et 78al found out an incidence of 35%,Pathania and sachar 
et al 21.8% ,Stearns et al 37%,Shah 79 et al 36%,Pathak et al 
32.5%,Lundback et al 63%,Liebow et al 42%,Bradley&Bryfogle et al 
40%,Anderson et al 77%,Ahuja et al 11%.
Incidence of coronary artery disease varies from 11to77 % in western 
literatures.Indian studies showed an incidence of 10 to 36%.The variation 
in the incidence of coronary artery disease may be explained by 
1.The difference in diagnostic criteria adopted by different authors,
2.The presence and absence of various risk factors in the selected study 
populations,
3.Phenotypic,genotypic and environmental variations,
4.Various bias. 
Incidence of coronary artery disease in general population  varies from 1 
to 6% as reported by Padmavathy Mathur et al and different authors.
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 The incidence of  myocardial infarction is 9.5% in the present study. 
Vaishnava et al 80reported an incidence of 8% whereas Bryfogle and 
Bradley reported 8.6%.
ANALYSIS OF HYPERTENSION
 In the present study  the incidence of hypertension was 21.1% . A 
significant percentage of CAD (23.4% )with p value <0.05 were observed 
among patients with systolic BP in the range of 140-160 mm of Hg.
In the Framingham study blood pressure of diabetic patients were 
significantly higher than in matched nondiabetic controls. 
Incidence of hypertension in diabetes mellitus  varies from 21.1% to 68% 
as reported by various authors.Our study showed an incidence of 
21.1%.The Framingham study81 showed an incidence of 54%,Balme and 
cole 60%,Banerjee  et al 8243.4%,Lundback et al 68%,Liebow et al 
34.8%,Pathania et al 27.8%.
Hypertension independently influences the incidence of coronary artery 
disease as reported by the Framingham study.Both systolic and diastolic 
hypertension influences the incidence.In diabetic patients hypertension 
accelerates coronary atherosclerosis.
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INCIDENCE OF CAD IN DIFFERENT AGE GROUPS
Atherosclerotic heart disease complicates the course of diabetes mellitus 
with increasing frequency in older age groups.
Our study showed an incidence of 40.6% in 50-60 years age 
group.Vaishnava et al 81reported an incidence of 37.3% in 50-60 years age 
group.Banerjee et al 79reported 87.7% in 70-80 years,Bradley Bryfogle 
89%,Pathania sachar 51.3%,Shah et al 8075%, Urset al 25% ,all in 70-80 
years.
Both Indian and western studies report that the incidence of CAD is 
negligible in less than 40 years.In the present study incidence in fourth 
decade  is 4.7%.
In the Framingham study patients who developed CAD belonged to 45-
64 years age group.
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INCIDENCE IN PREMENOPAUSAL V/S POSTMENOPAUSAL 
WOMEN
Premenopausal women are relatively free of CAD.Oliver et al reported a 
male female ratio of 16:1 below 40 years of age,7:1 in the fifth 
decade,1:1 above 70 years of age.
The protection against atherosclerosis in premenopausal 
women is almost completely lost in women with diabetes. 38
Among the Indian studies Pathania and Sachar,Vaishnava et al81 reported 
equal sex incidence where as  Pathak et al ,Banerjee et al,Urs and Shah 
observed a 2:1male:female ratio.Incidence of coronary artery disease is 
more in diabetic women than non diabetics.
In Our study CAD incidence was 79.7% in the postmenopausal and 
20.3% in the premenopausal age group.
Framingham  study and a recent meta analysis of 37 propective cohort 
studies revealed excess mortality from CAD in diabetic women18.
OBESITY AND CAD
Obesity increases the CAD risk independently and through  the associated 
metabolic syndrome components.Obesity has  influence on the insulin 
secretion,insulin sensitivity and the lipoprotein metabolism. 
Waist circumference (WC), waist-to-height ratio (WHeiR), and BMI 
are indicators for obesity. Our study examined the usefulness of 
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these indicators for coronary artery disease (CAD) type 2 diabetic 
women patients 
BODY MASS INDEX AND CAD83,84
In our study CAD incidence was significantly higher in overweight 
patients with BMI 25-29.9(59.4%),15.6% in obese patients(BMI>30)and 
25% in patients with normal weight. 
ANALYSIS OF WAIST CIRCUMFERENCE85,86
Several studies have reported that waist circumference >88cm in women 
increases the risk of CAD.
 In our study 67.2% had waist circumference >88 cm, 32.8% had waist 
circumference <88 cm. 
ANALYSIS OF WAIST- HEIGHT RATIO
A study in Taiwanese type 2 diabetic patients had concluded that 
WHeiR has the superiority of independent association with CAD 
and the highest magnitude of association than WC, WHR, and 
BMI in both sexes54. 
Our study examined the usefulness of waist-to-height ratio (WHeiR)as an 
indicator for (CAD). 56.3% of CAD patients had WHeiR<0.56 and 
43.8% had WHeiR>0.56.No significant correlation can be made from 
WHeiR and incidence of CAD from our study.
GLYCEMIC CONTROL AND INCIDENCE OF CAD
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The importance of glycemic control in preventing  the development and 
progression of long term complications of diabetes mellitus  was proven 
by different studies.87
Diabetes control and complications trial and UKPDS  were among the 
few important studies.88,89,90 In the DCCT  there was 41% risk reduction 
for macrovascular complications in tightly controlled type 1 diabetic 
patients. 
In our study of PPBS and the incidence of CAD,maximum incidence is 
found in 200-250 mg% range(34.4%);26% in 140-200mg% range,20.3% 
in 250-300mg% range and 0 % in<140 mg % range.
In our study of FBS and incidence of coronary artery disease significant 
number of patients had FBS >125 mg%(78.1%).
LIPIDS AND INCIDENCE OF CAD
Lipoprotein abnormalities are common in diabetes and contribute 
significantly to its complications .91 several studies of the Lipid Profile 
Pattern in Diabetics from India92 have been demonstrated a significant 
relationship between hypercholesterolemia and CAD.93,94 However, in 
Madras, India, 75% of people with myocardial infarction (MI) had 
plasma cholesterol levels less than 200 mg/dl .In another study from 
India, even lower level of plasma cholesterol (<150 mg/dl) in patients 
with CAD has been reported
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In our study ,significant correlation was found between 
hypercholesterolemia and the incidence of coronary artery disease.67.2% 
of coronary artery disease patients had moderate 
hypercholesterolemia(210-250mg%) and 9.4% had 
hypercholesterolemia(>250mg%).
Studies done by Sunil Gupta Diabetes Care Center, Nagpur India 95,96in 
patients with established acute myocardial infarction (AMI) with or 
without diabetes and a publication from Bangalore on diabetics with 
CAD showed serum triglycerides levels to be higher in the diabetic group 
whereas other lipid fractions were nearly similar and not significantly 
elevated as would have been expected.
In our study of correlation between serum triglycerides and the incidence 
of coronary artery disease,60.9% of the CAD patients had triglycerides 
>150mg%.
OCCUPATION AND CAD
Vaishnava et al 81reported an incidence of 44.7% of CAD in sedentary 
group,34.8% in moderatively active and 21.5% in manual labourers.
In our study the following results were obtained  .Among the 64  CAD 
patients 26 had sedentary jobs(40.6%),14 were manual 
labourers(21.9%).There was a significant correlation between sedentary 
occupation and increased incidence of CAD.
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STRESS AND CAD
Several studies including the one by Vaishnava et al81 have reported the 
role of mental stress and the increased risk of CAD.31,32
 In our study a significant proportion (28 out of the 64) of patients 
reported 'high' levels of subjective stress in the 2-4 week period preceding 
acute coronary events.
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CONCLUSION
1)Incidence of CAD,including myocardial infarction,in type 2 
diabetic women was 37.6%.
2)Incidence of myocardial infarction was 9.5%.
3)Incidence of CAD in post menopausal type 2 diabetic women 
was 79.7%.Incidence in pre menopausal women was 20.3%.
4)Incidence of CAD was maximum in  age group 50-60 
years(40.6%).
5)Incidence of hypertension was maximum in  age group 50-60 
years(39.3%)
6) A significant percentage of CAD (23.4%) with p value <0.05 were 
observed among patients with systolic BP in the range of 140-160 mm of 
Hg.
7) Incidence of CAD among patients  with sedentary occupations was 
(40.6%).
8) In the study a significant proportion (28 out of the 64 patients) reported 
'high' levels of subjective stress in the 2-4 week period preceding acute 
coronary events. 
9) In the study  of 64 CAD patients 59.4% were overweight and 15.6% 
were obese .
10)67.2% of the  CAD patients had waist circumference >88 cm.
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11) In the study of PPBS and the incidence of CAD,maximum incidence 
was found in 200-250 mg% range(34.4%)and 20.3% in 250-300mg% 
range.
12)Maximum incidence of CAD was found in patients with FBS>125 mg
% (78.1%). 
13)Moderate hypercholesterolemia (210-250 mg% ) was observed in 
67.2% of coronary artery disease patients and hypercholesterolemia(>250 
mg%) in9.4%. 
14)In the study 60.9% of the CAD patients had triglycerides >150mg%.
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APPENDIX-3
ABBREVIATIONS
CAD=CORONARY ARTERY DISEASE
BMI=BODY MASS INDEX
SBP=SYSTOLIC BP
DBP=DIASTOLIC BP
TG=TRIGLYCERIDES
WHEiR=WAIST TO HEIGHT RATIO
OCCUPATION:   1=SEDENTARY,2=MODERATE 
EXERTION,3=MANUAL LABOURER
ALL SYMPTOMS- 0=ABSENT,1=PRESENT
MENSTRUAL H/O-PM=POST MENOPAUSAL,M=MENSTRUATING
PAST ILLNESS-NA= NO ABNORMALITIES,HT=HYPERTENSION
FAMILY H/O-NA= NO ABNORMALITIES,D=DIABETES 
MELLITUS,C=CAD,H=HYPERTENSION
PALLONC=NON STEMI&CD,SA=STEMI&ARRYTHMIAS
ECHO-N=NORMAL,R=REGIONAL WALL MOTION 
ABNORMALITIES(RWMA),RL=RWMA&LEFT VENTRICULAR 
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